Kiniksa Pharmaceuticals International, plc Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
Kiniksa Pharmaceuticals International, plc (KNSA) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period of 521.44 thousand shares for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-28.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod · last filed 2024-02-28
- Kiniksa Pharmaceuticals International, plc share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2023 was 521.44K shares, a 107.91% increase from fiscal 2022.
- Kiniksa Pharmaceuticals International, plc share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2022 was 250.81K shares.
- Kiniksa Pharmaceuticals International, plc share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2020 was 80.70K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 12 month |
|---|---|
| 2023-12-31 | 521.44K shares 10-K · filed 2024-02-28 |
| 2022-12-31 | 250.81K shares 10-K · filed 2023-03-02 |
| 2020-12-31 | 80.70K shares 10-K · filed 2021-02-25 |